NPM1 and prostate adenocarcinoma: Our finding is consistent with higher NPM1 expression observed in various cancer types, including prostate adenocarcinoma, lung adenocarcinoma, colorectal cancer, pancreatic ductal adenocarcinoma, breast cancer, and bladder cancer.